Literature DB >> 17046257

Synthesis and antifungal activity of 1H-indole-4,7-diones.

Chung-Kyu Ryu1, Jung Yoon Lee, Rae-Eun Park, Mi-Young Ma, Ji-Hee Nho.   

Abstract

1H-Indole-4,7-diones were synthesized and tested for in vitro antifungal activity against fungi. The synthesized 1H-indole-4,7-diones generally showed good antifungal activity against Candida krusei, Cryptococcus neoformans, and Aspergillus niger. The results suggest that 1H-indole-4,7-diones would be potent antifungal agents.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17046257     DOI： 10.1016/j.bmcl.2006.09.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  4 in total

1.  Cu(II) complex with auxin (3-indoleacetic acid) and an aromatic planar ligand: synthesis, crystal structure, biomolecular interactions and radical scavenging activity.

Authors:  Duygu İnci; Rahmiye Aydın; Yunus Zorlu
Journal:  Eur Biophys J       Date:  2021-04-30       Impact factor: 1.733

2.  Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide.

Authors:  Hanif Shirinzadeh; Sibel Süzen; Nurten Altanlar; Andrew D Westwell
Journal:  Turk J Pharm Sci       Date:  2018-11-20

Review 3.  Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell
Journal:  Med Chem Res       Date:  2021-09-28       Impact factor: 1.965

4.  Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity.

Authors:  Jebiti Haribabu; Vasavi Garisetti; Rahime Eshaghi Malekshah; Swaminathan Srividya; Dasararaju Gayathri; Nattamai Bhuvanesh; Ramalinga Viswanathan Mangalaraja; Cesar Echeverria; Ramasamy Karvembu
Journal:  J Mol Struct       Date:  2021-10-21       Impact factor: 3.196
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.